What are the obstacles to innovation in the pharmaceutical industry? Summer 11 The Pistoia Alliance Summer Innovation is a key word throughout the pharmaceutical industry and the healthcare community and its pursuit is a business imperative for Pharma.
IP rights and EU pharmaceutical incentives enable innovation for the cures of tomorrow. In this interview, part of our Biopharma Frontiers series on how the pharmaceutical industry is evolving and how leaders can adapt, Epstein discusses the next horizon of innovation, critical elements of an effective business, and the kind of culture he tries to foster. An edited transcript of their conversation follows. Over 40 Years Of Leadership. Dedicated to the development and manufacturing of pharmaceutical solutions with international quality standards, Pharmaceutical Solutions Industry Ltd. is a fully integrated pharmaceutical company thriving on a culture of innovation and excellence. PSI, is the leading and the largest producer of a wide range of sterile IV solutions in the MENA region.
Innovation uptake in eHealth with patient-centeredness and gamification. Regulatory challenges and opportunities. Oct 02, Scope of the meeting: Brainstorm the status of the regulatory and ethical scenario in the context of eHealth and expose the state of the art of three EU H eHealth projects discussing the process-to-market implications especially at the light of the Regulatory framework in the clinical research and uptake in Our starting point was the multidisciplinary skill-set that was brought by the partners, covering ICT, medical, clinical knowledge and the deep understanding of the needs that the healthcare sector has.
Despite our people-centric profile, we Find out more about us. Sofoklis holds the position of Associate Professor in Aarhus University, where his activities are focused around Innovation Management and Entrepreneurship.
Sofoklis has published more than publications in international conferences, journals, books and standardization bodies and has more than citations. In after having steered successfully the company from the position of Managing Director, he resigned to co-found Innovation Sprint Sprl and he is currently the CEO of the company.
He has worked in the European Commission in Brussels and he has been a senior consultant to the Directorate General for Research of the Italian Ministry of Health for international activities. Worked as an Architect and later as a PM in large project developments.Disclosure UK.
The relationship between the pharmaceutical industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) plays a vital role in the development and delivery of life-enhancing and life-saving medicines. The global pharmaceutical industry’s investment in research and development is second, barely, to the computer and electronics industry and well beyond that of .
The single source for complete biopharmaceutical manufacturing solutions to safely and cost effectively process all dosage forms for life-enhancing drugs. In this interview, part of our Biopharma Frontiers series on how the pharmaceutical industry is evolving and how leaders can adapt, Epstein discusses the next horizon of innovation, critical elements of an effective business, and the kind of culture he tries to foster.
An edited transcript of their conversation follows. A Lifeline for Blood Cancer. The battle against blood cancer is one that can strike early, often beginning in childhood.
But thanks to the unstoppable resolve of researchers, groundbreaking treatments can now harness the body's own cells to power the fight and help give back time to patients and their families.
Managing innovation in pharma Pharmaceutical industry perspectives on the Global Innovation Survey The insatiable appetite of society, investors and patients for pharmaceutical innovation is linked to the breakthrough advances in science and technology by the innovation process.
Managing small steps in that.